There were 2,395 press releases posted in the last 24 hours and 441,428 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Stort, succesfuldt klinisk fase 3-studie når sit primære endemål og bekræfter potentialet af ALK's tabletvaccine mod husstøvmideallergi hos børn

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image